Martins FF, Marinho TS, Cardoso LEM, Barbosa-Da-Silva S, et al
u an Alzheimer ve Parkinson hastalar zerinde yrtlen Faz 3 almalar, bu ilac potansiyel bir demans nleyici olarak n sraya tayor
At the start of this year, many Californians lost Medicaid coverage for GLP-1 drugs prescribed for weight loss
Those who have switched from a brand-name GLP-1 to a compounded version are twice as likely as those who have switched from compounded to brand-name to cite cost or insurance coverage as their primary reason for switching (66% vs
These platforms have demonstrated a 20% improvement in treatment compliance and a 15% reduction in therapy discontinuation
While these findings provide biological plausibility for a direct cardiac mechanism, they do not demonstrate functional receptor activity or confirm that semaglutide acts directly on these cells